Current review of the SarQoL®: a health-related quality of life questionnaire specific to sarcopenia [0.03%]
萨尔QoL®现状评价：一种特异性肌少症健康相关生活质量问卷
Charlotte Beaudart,Jean-Yves Reginster,Anton Geerinck et al.
Charlotte Beaudart et al.
Sarcopenia, defined by a progressive and generalized loss of muscle mass and muscle function, is associated with many harmful clinical consequences. Several studies have reported the impact of sarcopenia on health-related quality of life (H...
A P Munasur-Naidoo,I Truter
A P Munasur-Naidoo
Recently, there has been a greater focus on adults with Attention-Deficit/Hyperactivity Disorder (ADHD) given that the symptoms persist in two-thirds of patients into adulthood. Areas covered: A systematic review of articles reporting on ad...
Cost-effectiveness of dolutegravir/abacavir/lamivudine in HIV-1 treatment-Naive (TN) patients in France [0.03%]
法国治疗-naïveHIV-1患者使用多替拉韦/阿巴卡韦/拉米夫定的疗效成本分析
Gilles Pialoux,Anne-Geneviève Marcelin,Hélène Cawston et al.
Gilles Pialoux et al.
Background: To evaluate the cost-effectiveness of an integrase inhibitor (INI), dolutegravir (DTG), in combination with abacavir (ABC)/lamivudine (3TC) in France, in treatment-naive (TN) HIV adult patients. ...
Corrigendum [0.03%]
勘误表
Social and economic burden of recurrent urinary tract infections and quality of life: a patient web-based study (GESPRIT) [0.03%]
复发性尿路感染的社会经济负担及对生活质量的影响：一项基于患者网络的调查（GESPRIT）研究
Florian Wagenlehner,Björn Wullt,Stefania Ballarini et al.
Florian Wagenlehner et al.
Background: Uncomplicated lower urinary tract infections (UTIs) occur in approximately 50% of women, and 20-30% experience recurrent UTI. Data on UTIs and quality of life (QoL) in Europe are limited. ...
Samantha N Steiger,Rachel R Comito,David P Nicolau
Samantha N Steiger
Urinary tract infections represent one of the most frequent reasons for hospitalization. As a result of their prevalence from community-based origins as well as those which develop in hospital setting, this constellation of infections repre...
Estimate of the cost of multiple sclerosis in Spain by literature review [0.03%]
西班牙多发性硬化症疾病负担的文献回顾及成本估算
Oscar Fernández,Miguel Angel Calleja-Hernández,José Meca-Lallana et al.
Oscar Fernández et al.
Multiple Sclerosis (MS) is a progressive disease leading to increasing disability and costs. A literature review was carried out to identify MS costs and to estimate its economic burden in Spain. Areas Covered: The public electronic databas...
Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder [0.03%]
共病注意缺陷多动障碍、情绪障碍和物质使用障碍的批判性探索
Judith Regnart,Ilse Truter,Anneke Meyer
Judith Regnart
Co-occurring disorders (CODs) describe a Substance Use Disorder (SUD) accompanied by a comorbid psychiatric disorder. Attention-Deficit/Hyperactivity Disorder (ADHD) and mood disorders are common CODs with high prevalence rates in SUD popul...
Micro factors bringing the pharmaceutical industry to a seismic shaking a qualitative research [0.03%]
微因素透视下的制药行业地震式变革定性研究报告
Raphaela Marie Louisa Dierks,Olivier Bruyère,Jean-Yves Reginster
Raphaela Marie Louisa Dierks
Introduction: Due to changing macro and micro factors, expiring patents and falling net income, pharmaceutical companies need to rethink their vertical business model. The trend shows cross-sectorial partnerships and cons...
Comparison of all-cause, stroke, and bleed-specific healthcare resource utilization among patients with non-valvular atrial fibrillation (NVAF) and newly treated with dabigatran or warfarin [0.03%]
非瓣膜性房颤患者初服用达比加群或华法林的全因、卒中及出血特异的卫生资源利用比较研究
Xue Song,Pranav Gandhi,Adrienne M Gilligan et al.
Xue Song et al.
Background: We compared healthcare utilization outcomes and persistence among non-valvular atrial fibrillation (NVAF) patients newly treated with dabigatran or warfarin. ...